Bliss GVS Pharma Ltd.
•₹ 579.1-0.18%
2026-08-21
PROS
- Company is almost debt free
- Company has consistently been profitable over the last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.13x)
- Company comfortably covers its interest (16.8x coverage)
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- A large part of profit comes from other income (46.6% of PBT)
- Valuation is stretched - P/E of 44.7 is well above its own 5-year median (15.6)
- Recurring exceptional / one-off items are inflating headline profit
- Though reporting repeated profits, the company pays out little dividend (12.3%)
- Expensive relative to growth - PEG of 2.2
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | BLISSGVS | 572.70 | 44.69 | 6086.38 | 0.26 | 51.37 | 15.80 | 285.58 | 37.65 | 17.40 | 26.75 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 | 212 | 201 | 198 | 184 | 218 | 210 | 198 | 207 | 244 | 218 | 257 | 286 | |
| 135 | 158 | 157 | 170 | 149 | 178 | 181 | 177 | 166 | 213 | 183 | 213 | 220 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 5 | 13 | 5 | 6 | 4 | 7 | 15 | 12 | 35 | 20 | 18 | 11 | 10 |
| Interest | 1 | 1 | 2 | 2 | 2 | 4 | 1 | 2 | 5 | 3 | 1 | 2 | 1 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 10 |
| 22 | 59 | 40 | -4 | 30 | 36 | 36 | 23 | 63 | 41 | 41 | 45 | 75 | |
| Tax % | 33.58% | 27.21% | 27.40% | -24.56% | 26.50% | 28.03% | 29.16% | 28.97% | 29.71% | 29.63% | 39.41% | 17.69% | 31.94% |
| Net Profit | 0 | 0 | 0 | 0 | 22 | 26 | 26 | 17 | 44 | 29 | 25 | 37 | 51 |
| 1 | 4 | 3 | -1 | 2 | 2 | 2 | 1 | 4 | 3 | 2 | 3 | 0 | |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 160
- 135
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 6
- 22
- Tax %
- 33.58%
- Net Profit
- 0
- 1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 212
- 158
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 1
- Depreciation
- 6
- 59
- Tax %
- 27.21%
- Net Profit
- 0
- 4
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 201
- 157
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 2
- Depreciation
- 7
- 40
- Tax %
- 27.40%
- Net Profit
- 0
- 3
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 198
- 170
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 2
- Depreciation
- 7
- -4
- Tax %
- -24.56%
- Net Profit
- 0
- -1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 184
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 2
- Depreciation
- 7
- 30
- Tax %
- 26.50%
- Net Profit
- 22
- 2
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 218
- 178
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 4
- Depreciation
- 7
- 36
- Tax %
- 28.03%
- Net Profit
- 26
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 210
- 181
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 1
- Depreciation
- 8
- 36
- Tax %
- 29.16%
- Net Profit
- 26
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 198
- 177
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 2
- Depreciation
- 8
- 23
- Tax %
- 28.97%
- Net Profit
- 17
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 207
- 166
- Operating Profit
- —
- OPM %
- —
- Other Income
- 35
- Interest
- 5
- Depreciation
- 8
- 63
- Tax %
- 29.71%
- Net Profit
- 44
- 4
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 244
- 213
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 3
- Depreciation
- 8
- 41
- Tax %
- 29.63%
- Net Profit
- 29
- 3
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 218
- 183
- Operating Profit
- —
- OPM %
- —
- Other Income
- 18
- Interest
- 1
- Depreciation
- 8
- 41
- Tax %
- 39.41%
- Net Profit
- 25
- 2
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 257
- 213
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 2
- Depreciation
- 9
- 45
- Tax %
- 17.69%
- Net Profit
- 37
- 3
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 286
- 220
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 10
- 75
- Tax %
- 31.94%
- Net Profit
- 51
- 0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 798 | 815 | 899 | 689 | 577 | 747 | 752 | 770 | 810 | 927 | 1,005 | |
| 596 | 618 | 741 | 566 | 471 | 629 | 634 | 620 | 683 | 778 | 828 | |
| Operating Profit | 215 | 224 | 195 | 163 | 129 | 150 | 135 | 179 | 163 | 238 | — |
| OPM % | 27 | 27 | 22 | 24 | 22 | 20 | 18 | 23 | 20 | 26 | — |
| Other Income | 13 | 27 | 38 | 39 | 22 | 31 | 18 | 29 | 36 | 88 | 59 |
| Interest | 20 | 23 | 4 | 8 | 7 | 5 | 10 | 7 | 8 | 12 | 7 |
| Depreciation | 20 | 21 | 9 | 13 | 17 | 17 | 19 | 26 | 29 | 33 | 35 |
| 175 | 145 | 182 | 129 | 104 | 54 | 106 | 117 | 126 | 190 | 202 | |
| Tax % | 36 | 39 | 30 | 26 | 29 | 57 | 28 | 30 | 28 | 29 | 30 |
| Net Profit | 113 | 89 | 127 | 95 | 74 | 23 | 77 | 82 | 90 | 135 | 142 |
| EPS | 0 | 0 | 0 | 0 | 6 | 1 | 7 | 7 | 8 | 12 | — |
| Dividend Payout % | 8 | 18 | 8 | 5 | 8 | 34 | 7 | 7 | 6 | 12 | — |
| Minority Interest | -31 | -30 | -3 | 2 | -5 | -8 | -6 | -6 | -6 | -6 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 6 | 12 | 9 | 7 | 1 | 7 | 7 | 8 | 12 | — |
| Minority Interest | -31 | -30 | -3 | 2 | -5 | -8 | -6 | -6 | -6 | -6 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 6 | 12 | 9 | 7 | 1 | 7 | 7 | 8 | 12 | — |
Mar 2017
- 798
- 596
- Operating Profit
- 215
- OPM %
- 27
- Other Income
- 13
- Interest
- 20
- Depreciation
- 20
- 175
- Tax %
- 36
- Net Profit
- 113
- EPS
- 0
- Dividend Payout %
- 8
- Minority Interest
- -31
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- -31
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2018
- 815
- 618
- Operating Profit
- 224
- OPM %
- 27
- Other Income
- 27
- Interest
- 23
- Depreciation
- 21
- 145
- Tax %
- 39
- Net Profit
- 89
- EPS
- 0
- Dividend Payout %
- 18
- Minority Interest
- -30
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- -30
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2019
- 899
- 741
- Operating Profit
- 195
- OPM %
- 22
- Other Income
- 38
- Interest
- 4
- Depreciation
- 9
- 182
- Tax %
- 30
- Net Profit
- 127
- EPS
- 0
- Dividend Payout %
- 8
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2020
- 689
- 566
- Operating Profit
- 163
- OPM %
- 24
- Other Income
- 39
- Interest
- 8
- Depreciation
- 13
- 129
- Tax %
- 26
- Net Profit
- 95
- EPS
- 0
- Dividend Payout %
- 5
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2021
- 577
- 471
- Operating Profit
- 129
- OPM %
- 22
- Other Income
- 22
- Interest
- 7
- Depreciation
- 17
- 104
- Tax %
- 29
- Net Profit
- 74
- EPS
- 6
- Dividend Payout %
- 8
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2022
- 747
- 629
- Operating Profit
- 150
- OPM %
- 20
- Other Income
- 31
- Interest
- 5
- Depreciation
- 17
- 54
- Tax %
- 57
- Net Profit
- 23
- EPS
- 1
- Dividend Payout %
- 34
- Minority Interest
- -8
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- -8
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2023
- 752
- 634
- Operating Profit
- 135
- OPM %
- 18
- Other Income
- 18
- Interest
- 10
- Depreciation
- 19
- 106
- Tax %
- 28
- Net Profit
- 77
- EPS
- 7
- Dividend Payout %
- 7
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 770
- 620
- Operating Profit
- 179
- OPM %
- 23
- Other Income
- 29
- Interest
- 7
- Depreciation
- 26
- 117
- Tax %
- 30
- Net Profit
- 82
- EPS
- 7
- Dividend Payout %
- 7
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2025
- 810
- 683
- Operating Profit
- 163
- OPM %
- 20
- Other Income
- 36
- Interest
- 8
- Depreciation
- 29
- 126
- Tax %
- 28
- Net Profit
- 90
- EPS
- 8
- Dividend Payout %
- 6
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2026
- 927
- 778
- Operating Profit
- 238
- OPM %
- 26
- Other Income
- 88
- Interest
- 12
- Depreciation
- 33
- 190
- Tax %
- 29
- Net Profit
- 135
- EPS
- 12
- Dividend Payout %
- 12
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 12
TTM
- 1,005
- 828
- Operating Profit
- —
- OPM %
- —
- Other Income
- 59
- Interest
- 7
- Depreciation
- 35
- 202
- Tax %
- 30
- Net Profit
- 142
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 5%
- 5 Years:
- 10%
- 3 Years:
- 7%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 5%
- 5 Years:
- 14%
- 3 Years:
- 22%
STOCK PRICE CAGR
- 10 Years:
- 16%
- 5 Years:
- 40%
- 3 Years:
- 85%
- 1 Year:
- 249%
RETURN ON EQUITY
- 10 Years:
- 13%
- 5 Years:
- 8%
- 3 Years:
- 10%
- Last Year:
- 12%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 |
| 476 | 526 | 636 | 725 | 788 | 798 | 865 | 949 | 1,034 | 1,171 | |
| 187 | 111 | 69 | 66 | 86 | 61 | 57 | 32 | 23 | 3 | |
| Trade Payables | 98 | 58 | 79 | 90 | 74 | 93 | 86 | 61 | 71 | 104 |
| 251 | 154 | 111 | 135 | 118 | 147 | 135 | 159 | 163 | 188 | |
| Total Liabilities | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,154 | 1,212 | 1,301 | 1,476 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 304 | 136 | 145 | 241 | 234 | 281 | 378 | 369 | 405 | 459 | |
| Capital Work in Progress | 4 | 0 | 47 | 0 | 2 | 22 | 3 | 8 | 21 | 6 |
| 1 | 6 | 1 | 1 | 0 | 2 | 8 | 4 | 4 | 5 | |
| 49 | 59 | 77 | 74 | 99 | 124 | 103 | 118 | 126 | 151 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 404 | 439 | 517 | |
| Cash & Bank | 150 | 89 | 107 | 103 | 145 | 178 | 103 | 216 | 213 | 167 |
| 514 | 569 | 528 | 608 | 597 | 502 | 559 | 92 | 93 | 172 | |
| Total Assets | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,154 | 1,212 | 1,301 | 1,476 |
| Total Debt | 225 | 118 | 102 | 121 | 119 | 105 | 98 | 88 | 71 | 3 |
| Net Working Capital | 129 | 390 | 486 | 539 | 562 | 544 | 504 | 653 | 644 | 711 |
| Contingent Liabilities | 44 | 4 | 2 | 14 | 30 | 23 | 12 | 57 | 5 | 11 |
| Book Value per Share | 47.18 | 51.99 | 62.63 | 71.32 | 77.41 | 78.01 | 84.01 | 91.65 | 99.09 | 111.66 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 225 | 118 | 102 | 121 | 119 | 105 | 98 | 88 | 71 | 3 |
| Net Working Capital | 129 | 390 | 486 | 539 | 562 | 544 | 504 | 653 | 644 | 711 |
| Contingent Liabilities | 44 | 4 | 2 | 14 | 30 | 23 | 12 | 57 | 5 | 11 |
| Book Value per Share | 47.18 | 51.99 | 62.63 | 71.32 | 77.41 | 78.01 | 84.01 | 91.65 | 99.09 | 111.66 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 10
- 476
- 187
- Trade Payables
- 98
- 251
- Total Liabilities
- 1,023
- 304
- Capital Work in Progress
- 4
- 1
- 49
- 0
- Cash & Bank
- 150
- 514
- Total Assets
- 1,023
- Total Debt
- 225
- Net Working Capital
- 129
- Contingent Liabilities
- 44
- Book Value per Share
- 47.18
- Face Value
- 1.00
- Total Debt
- 225
- Net Working Capital
- 129
- Contingent Liabilities
- 44
- Book Value per Share
- 47.18
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 10
- 526
- 111
- Trade Payables
- 58
- 154
- Total Liabilities
- 860
- 136
- Capital Work in Progress
- 0
- 6
- 59
- 0
- Cash & Bank
- 89
- 569
- Total Assets
- 860
- Total Debt
- 118
- Net Working Capital
- 390
- Contingent Liabilities
- 4
- Book Value per Share
- 51.99
- Face Value
- 1.00
- Total Debt
- 118
- Net Working Capital
- 390
- Contingent Liabilities
- 4
- Book Value per Share
- 51.99
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 10
- 636
- 69
- Trade Payables
- 79
- 111
- Total Liabilities
- 905
- 145
- Capital Work in Progress
- 47
- 1
- 77
- 0
- Cash & Bank
- 107
- 528
- Total Assets
- 905
- Total Debt
- 102
- Net Working Capital
- 486
- Contingent Liabilities
- 2
- Book Value per Share
- 62.63
- Face Value
- 1.00
- Total Debt
- 102
- Net Working Capital
- 486
- Contingent Liabilities
- 2
- Book Value per Share
- 62.63
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 10
- 725
- 66
- Trade Payables
- 90
- 135
- Total Liabilities
- 1,027
- 241
- Capital Work in Progress
- 0
- 1
- 74
- 0
- Cash & Bank
- 103
- 608
- Total Assets
- 1,027
- Total Debt
- 121
- Net Working Capital
- 539
- Contingent Liabilities
- 14
- Book Value per Share
- 71.32
- Face Value
- 1.00
- Total Debt
- 121
- Net Working Capital
- 539
- Contingent Liabilities
- 14
- Book Value per Share
- 71.32
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 10
- 788
- 86
- Trade Payables
- 74
- 118
- Total Liabilities
- 1,077
- 234
- Capital Work in Progress
- 2
- 0
- 99
- 0
- Cash & Bank
- 145
- 597
- Total Assets
- 1,077
- Total Debt
- 119
- Net Working Capital
- 562
- Contingent Liabilities
- 30
- Book Value per Share
- 77.41
- Face Value
- 1.00
- Total Debt
- 119
- Net Working Capital
- 562
- Contingent Liabilities
- 30
- Book Value per Share
- 77.41
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 10
- 798
- 61
- Trade Payables
- 93
- 147
- Total Liabilities
- 1,109
- 281
- Capital Work in Progress
- 22
- 2
- 124
- 0
- Cash & Bank
- 178
- 502
- Total Assets
- 1,109
- Total Debt
- 105
- Net Working Capital
- 544
- Contingent Liabilities
- 23
- Book Value per Share
- 78.01
- Face Value
- 1.00
- Total Debt
- 105
- Net Working Capital
- 544
- Contingent Liabilities
- 23
- Book Value per Share
- 78.01
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 10
- 865
- 57
- Trade Payables
- 86
- 135
- Total Liabilities
- 1,154
- 378
- Capital Work in Progress
- 3
- 8
- 103
- 0
- Cash & Bank
- 103
- 559
- Total Assets
- 1,154
- Total Debt
- 98
- Net Working Capital
- 504
- Contingent Liabilities
- 12
- Book Value per Share
- 84.01
- Face Value
- 1.00
- Total Debt
- 98
- Net Working Capital
- 504
- Contingent Liabilities
- 12
- Book Value per Share
- 84.01
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 10
- 949
- 32
- Trade Payables
- 61
- 159
- Total Liabilities
- 1,212
- 369
- Capital Work in Progress
- 8
- 4
- 118
- 404
- Cash & Bank
- 216
- 92
- Total Assets
- 1,212
- Total Debt
- 88
- Net Working Capital
- 653
- Contingent Liabilities
- 57
- Book Value per Share
- 91.65
- Face Value
- 1.00
- Total Debt
- 88
- Net Working Capital
- 653
- Contingent Liabilities
- 57
- Book Value per Share
- 91.65
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 11
- 1,034
- 23
- Trade Payables
- 71
- 163
- Total Liabilities
- 1,301
- 405
- Capital Work in Progress
- 21
- 4
- 126
- 439
- Cash & Bank
- 213
- 93
- Total Assets
- 1,301
- Total Debt
- 71
- Net Working Capital
- 644
- Contingent Liabilities
- 5
- Book Value per Share
- 99.09
- Face Value
- 1.00
- Total Debt
- 71
- Net Working Capital
- 644
- Contingent Liabilities
- 5
- Book Value per Share
- 99.09
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 11
- 1,171
- 3
- Trade Payables
- 104
- 188
- Total Liabilities
- 1,476
- 459
- Capital Work in Progress
- 6
- 5
- 151
- 517
- Cash & Bank
- 167
- 172
- Total Assets
- 1,476
- Total Debt
- 3
- Net Working Capital
- 711
- Contingent Liabilities
- 11
- Book Value per Share
- 111.66
- Face Value
- 1.00
- Total Debt
- 3
- Net Working Capital
- 711
- Contingent Liabilities
- 11
- Book Value per Share
- 111.66
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 289 | 18 | 40 | 47 | 64 | 135 | 34 | 103 | 106 | 139 | |
| Cash from Investing | -231 | 50 | -74 | -48 | -47 | -93 | -8 | -83 | -76 | -38 |
| Cash from Financing | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 | -89 |
| 48 | -8 | -17 | -7 | -4 | 19 | 2 | -1 | 0 | 11 | |
| Free Cash Flow | 268 | 18 | -19 | -13 | 53 | 57 | -62 | 89 | 30 | 77 |
| OCF / Net Profit | 2.57 | 0.20 | 0.32 | 0.49 | 0.86 | 5.86 | 0.45 | 1.26 | 1.17 | 1.03 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 307 | 96 | 17 | 124 | 167 | 191 |
| OCF / Net Profit | 2.57 | 0.20 | 0.32 | 0.49 | 0.86 | 5.86 | 0.45 | 1.26 | 1.17 | 1.03 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 307 | 96 | 17 | 124 | 167 | 191 |
Mar 2017
- 289
- Cash from Investing
- -231
- Cash from Financing
- -10
- 48
- Free Cash Flow
- 268
- OCF / Net Profit
- 2.57
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.57
- Cumulative 5-Year FCF
- 0
Mar 2018
- 18
- Cash from Investing
- 50
- Cash from Financing
- -76
- -8
- Free Cash Flow
- 18
- OCF / Net Profit
- 0.20
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.20
- Cumulative 5-Year FCF
- 0
Mar 2019
- 40
- Cash from Investing
- -74
- Cash from Financing
- 17
- -17
- Free Cash Flow
- -19
- OCF / Net Profit
- 0.32
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.32
- Cumulative 5-Year FCF
- 0
Mar 2020
- 47
- Cash from Investing
- -48
- Cash from Financing
- -6
- -7
- Free Cash Flow
- -13
- OCF / Net Profit
- 0.49
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.49
- Cumulative 5-Year FCF
- 0
Mar 2021
- 64
- Cash from Investing
- -47
- Cash from Financing
- -21
- -4
- Free Cash Flow
- 53
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- 307
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- 307
Mar 2022
- 135
- Cash from Investing
- -93
- Cash from Financing
- -24
- 19
- Free Cash Flow
- 57
- OCF / Net Profit
- 5.86
- Cumulative 5-Year FCF
- 96
- OCF / Net Profit
- 5.86
- Cumulative 5-Year FCF
- 96
Mar 2023
- 34
- Cash from Investing
- -8
- Cash from Financing
- -25
- 2
- Free Cash Flow
- -62
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 17
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 17
Mar 2024
- 103
- Cash from Investing
- -83
- Cash from Financing
- -21
- -1
- Free Cash Flow
- 89
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 124
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 124
Mar 2025
- 106
- Cash from Investing
- -76
- Cash from Financing
- -30
- 0
- Free Cash Flow
- 30
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 167
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 167
Mar 2026
- 139
- Cash from Investing
- -38
- Cash from Financing
- -89
- 11
- Free Cash Flow
- 77
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 191
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 191
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 7.95 | 5.70 | 11.99 | 9.43 | 6.64 | 1.45 | 6.80 | 7.21 | 8.00 | 12.21 |
| Book Value (₹) | 47.18 | 51.99 | 62.63 | 71.32 | 77.41 | 78.01 | 84.01 | 91.65 | 99.09 | 111.66 |
| Dividend per Share (₹) | 0.60 | 1.00 | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.50 |
| Cash EPS (₹) | 12.88 | 10.67 | 13.15 | 10.46 | 8.84 | 3.90 | 9.16 | 10.31 | 11.36 | 15.90 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 26.83% | 27.44% | 21.73% | 23.57% | 22.28% | 20.05% | 17.98% | 19.56% | 15.04% | 15.41% |
| Net Margin % | 14.04% | 10.88% | 14.10% | 13.82% | 12.82% | 3.09% | 10.21% | 10.59% | 10.71% | 13.91% |
| ROE % | 25.06% | 17.34% | 21.43% | 13.79% | 9.64% | 2.88% | 9.11% | 8.89% | 9.01% | 12.11% |
| ROCE % | 31.06% | 24.61% | 26.58% | 17.02% | 12.49% | 6.37% | 12.22% | 12.15% | 12.29% | 17.40% |
| 11.88% | 9.42% | 14.35% | 9.86% | 7.03% | 2.12% | 6.78% | 6.90% | 7.18% | 9.70% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 126 | 124 | 154 | 267 | 320 | 209 | 189 | 187 | 183 | 180 |
| Inventory Days | 20 | 24 | 28 | 40 | 55 | 54 | 55 | 52 | 53 | 52 |
| Payable Days | 105 | 73 | 41 | 70 | 91 | 78 | 81 | 70 | 58 | 75 |
| 41 | 75 | 141 | 237 | 284 | 186 | 163 | 169 | 177 | 157 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.46x | 0.22x | 0.16x | 0.16x | 0.15x | 0.13x | 0.11x | 0.09x | 0.07x | 0.00x |
| Interest Coverage (x) | 9.91x | 7.37x | 42.21x | 18.04x | 15.38x | 12.42x | 11.23x | 17.91x | 16.47x | 16.79x |
| 1.29x | 2.30x | 3.35x | 3.34x | 3.76x | 3.33x | 3.61x | 5.15x | 4.74x | 4.02x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 45.99% | 2.03% | 10.30% | -23.29% | -16.26% | 29.50% | 0.55% | 2.48% | 5.13% | 14.50% |
| Operating Profit Growth % | 19.53% | 3.92% | -12.70% | -16.78% | -20.86% | 16.51% | -9.83% | 32.75% | -9.02% | 45.59% |
| Net Profit Growth % | 12.52% | -21.32% | 42.86% | -24.80% | -22.34% | -68.74% | 231.80% | 6.31% | 10.64% | 49.27% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.94% | 11.00% | 52.57% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 15.63x | 14.69x | 17.66x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.23x | 1.19x | 1.93x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.44% | 0.43% | 0.70% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.86x | 6.72x | 8.91x |
Mar 2017
- EPS (₹)
- 7.95
- Book Value (₹)
- 47.18
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 12.88
- Operating Margin %
- 26.83%
- Net Margin %
- 14.04%
- ROE %
- 25.06%
- ROCE %
- 31.06%
- 11.88%
- Debtor Days
- 126
- Inventory Days
- 20
- Payable Days
- 105
- 41
- Debt to Equity (x)
- 0.46x
- Interest Coverage (x)
- 9.91x
- 1.29x
- Revenue Growth %
- 45.99%
- Operating Profit Growth %
- 19.53%
- Net Profit Growth %
- 12.52%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 5.70
- Book Value (₹)
- 51.99
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 10.67
- Operating Margin %
- 27.44%
- Net Margin %
- 10.88%
- ROE %
- 17.34%
- ROCE %
- 24.61%
- 9.42%
- Debtor Days
- 124
- Inventory Days
- 24
- Payable Days
- 73
- 75
- Debt to Equity (x)
- 0.22x
- Interest Coverage (x)
- 7.37x
- 2.30x
- Revenue Growth %
- 2.03%
- Operating Profit Growth %
- 3.92%
- Net Profit Growth %
- -21.32%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 11.99
- Book Value (₹)
- 62.63
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 13.15
- Operating Margin %
- 21.73%
- Net Margin %
- 14.10%
- ROE %
- 21.43%
- ROCE %
- 26.58%
- 14.35%
- Debtor Days
- 154
- Inventory Days
- 28
- Payable Days
- 41
- 141
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 42.21x
- 3.35x
- Revenue Growth %
- 10.30%
- Operating Profit Growth %
- -12.70%
- Net Profit Growth %
- 42.86%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 9.43
- Book Value (₹)
- 71.32
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 10.46
- Operating Margin %
- 23.57%
- Net Margin %
- 13.82%
- ROE %
- 13.79%
- ROCE %
- 17.02%
- 9.86%
- Debtor Days
- 267
- Inventory Days
- 40
- Payable Days
- 70
- 237
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 18.04x
- 3.34x
- Revenue Growth %
- -23.29%
- Operating Profit Growth %
- -16.78%
- Net Profit Growth %
- -24.80%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.64
- Book Value (₹)
- 77.41
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 8.84
- Operating Margin %
- 22.28%
- Net Margin %
- 12.82%
- ROE %
- 9.64%
- ROCE %
- 12.49%
- 7.03%
- Debtor Days
- 320
- Inventory Days
- 55
- Payable Days
- 91
- 284
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 15.38x
- 3.76x
- Revenue Growth %
- -16.26%
- Operating Profit Growth %
- -20.86%
- Net Profit Growth %
- -22.34%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 1.45
- Book Value (₹)
- 78.01
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 3.90
- Operating Margin %
- 20.05%
- Net Margin %
- 3.09%
- ROE %
- 2.88%
- ROCE %
- 6.37%
- 2.12%
- Debtor Days
- 209
- Inventory Days
- 54
- Payable Days
- 78
- 186
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 12.42x
- 3.33x
- Revenue Growth %
- 29.50%
- Operating Profit Growth %
- 16.51%
- Net Profit Growth %
- -68.74%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.80
- Book Value (₹)
- 84.01
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 9.16
- Operating Margin %
- 17.98%
- Net Margin %
- 10.21%
- ROE %
- 9.11%
- ROCE %
- 12.22%
- 6.78%
- Debtor Days
- 189
- Inventory Days
- 55
- Payable Days
- 81
- 163
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 11.23x
- 3.61x
- Revenue Growth %
- 0.55%
- Operating Profit Growth %
- -9.83%
- Net Profit Growth %
- 231.80%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 7.21
- Book Value (₹)
- 91.65
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 10.31
- Operating Margin %
- 19.56%
- Net Margin %
- 10.59%
- ROE %
- 8.89%
- ROCE %
- 12.15%
- 6.90%
- Debtor Days
- 187
- Inventory Days
- 52
- Payable Days
- 70
- 169
- Debt to Equity (x)
- 0.09x
- Interest Coverage (x)
- 17.91x
- 5.15x
- Revenue Growth %
- 2.48%
- Operating Profit Growth %
- 32.75%
- Net Profit Growth %
- 6.31%
- 5.94%
- P/E (x)
- 15.63x
- P/B (x)
- 1.23x
- Dividend Yield %
- 0.44%
- 5.86x
Mar 2025
- EPS (₹)
- 8.00
- Book Value (₹)
- 99.09
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 11.36
- Operating Margin %
- 15.04%
- Net Margin %
- 10.71%
- ROE %
- 9.01%
- ROCE %
- 12.29%
- 7.18%
- Debtor Days
- 183
- Inventory Days
- 53
- Payable Days
- 58
- 177
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 16.47x
- 4.74x
- Revenue Growth %
- 5.13%
- Operating Profit Growth %
- -9.02%
- Net Profit Growth %
- 10.64%
- 11.00%
- P/E (x)
- 14.69x
- P/B (x)
- 1.19x
- Dividend Yield %
- 0.43%
- 6.72x
Mar 2026
- EPS (₹)
- 12.21
- Book Value (₹)
- 111.66
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 15.90
- Operating Margin %
- 15.41%
- Net Margin %
- 13.91%
- ROE %
- 12.11%
- ROCE %
- 17.40%
- 9.70%
- Debtor Days
- 180
- Inventory Days
- 52
- Payable Days
- 75
- 157
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 16.79x
- 4.02x
- Revenue Growth %
- 14.50%
- Operating Profit Growth %
- 45.59%
- Net Profit Growth %
- 49.27%
- 52.57%
- P/E (x)
- 17.66x
- P/B (x)
- 1.93x
- Dividend Yield %
- 0.70%
- 8.91x
Documents
Announcements
- Shareholders meeting
2026-08-20 - Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
- Copy of Newspaper Publication
2026-08-14 - Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the extract of the statement of un-audited standalone andconsolidated financial results for the quarter ended June 30, 2026.
Annual Reports
Credit Ratings
Nothing filed yet.